This document discusses labeling, storage, stability, and beyond use dates of pharmaceutical dosage forms. It covers the key information that must be included on labels like the drug name, strength, instructions. Proper storage conditions are outlined for different dosage forms to protect stability based on factors like temperature, light, and moisture. The importance of stability is explained to maintain the drug's therapeutic properties over time. The beyond use date is defined as the last date the patient should use the medication by based on stability considerations.
The document discusses packaging of pharmaceutical products. It describes the functions of packaging as presentation, identification, protection, convenience and containment. It outlines different types of packaging for solid, semi-solid and liquid products. It also discusses components of packaging including various materials used like glass, plastics, metals and rubbers. Different types of containers and closures are explained along with common packaging types like blister packs.
The document discusses evaluation and stability studies of tablets. It provides details on common tablet tests performed during evaluation including general appearance, hardness, friability, weight variation, disintegration, and dissolution. It also discusses factors affecting drug stability and the various types of stability that must be considered, including chemical, physical, microbiological, therapeutic, and toxicological stability. Guidelines for stability testing from ICH, USP, FDA and other organizations are also summarized regarding testing conditions, frequency, and requirements for re-testing tablets after registration.
This lecture discusses pharmaceutical powders. It begins by defining a pharmaceutical powder as a solid dosage form containing finely divided drugs or chemicals meant for internal or external use. Powders permit drugs to be reduced to a very fine state, enhancing dissolution rate, absorption, and masking unpleasant tastes. The lecture then covers various types of powders including divided powders for internal use (simple, compound, cachet-enclosed), bulk powders (antacids, laxatives), and powders for external use. Methods for reducing particle size like trituration, pulverization, and levigation are also summarized.
This document discusses the labeling of pharmaceutical products. Labeling provides important information for patients, including instructions for appropriate use of medicines. Labels must include the product name, quantity, patient name, dispensing date and pharmacy details. Labels also provide storage instructions, dosage information, potential drug interactions and warnings. Special labeling is required for different types of drug formulations and delivery methods, such as inhalers, capsules, creams and injections. The goal of labeling is to ensure safe use of approved pharmaceutical products and distinguish brands.
This document discusses various aspects of packaging for sterile dosage forms. It begins by defining packaging and describing its purposes such as protecting products and preventing contamination. It then discusses different types of primary, secondary, and tertiary packaging as well as packaging materials like glass, plastic, rubber, and metals. Key characteristics and selection criteria for packaging materials are outlined. The document also covers packaging related topics such as quality assurance, sampling, testing, and validation.
This document provides an overview of tablet formulation and manufacturing. It discusses the definition and advantages of tablets as a popular dosage form. It describes different types of tablets including compressed, enteric coated, and chewable tablets. The document outlines the manufacturing process for compressed tablets including preparation of granules through wet and dry granulation. It also discusses common excipients used in tablet formulations such as diluents, binders, and lubricants. Finally, it provides information on tablet coating techniques and quality evaluation tests for tablets.
Powders are mixtures of finely divided drugs and chemicals that can be used internally or externally. Powders consist of particles that can range in size from 10 mm to 1 μm. The particle size distribution and properties influence how powders can be used. Before using powders to make pharmaceutical products, their chemical and physical characteristics like morphology, purity, solubility, and stability are analyzed. Proper blending and avoiding segregation of powder mixtures is important for ensuring uniform and consistent dosing.
Granules are aggregations of fine powder particles that are roughly spherical in shape. They are produced to improve powder flowability, enhance compressibility, reduce toxicity, and prevent caking. There are three main granulation methods: wet granulation, dry granulation, and granulation by crystallization. Wet granulation is most common and involves mixing powder with a liquid to form a paste, then granulating and drying the paste. Granules are sieved after drying to achieve a uniform size distribution suitable for their intended use as a final or intermediate pharmaceutical product. Quality tests such as dissolution and friability are performed to ensure granule properties are suitable.
The document discusses packaging of pharmaceutical products. It describes the functions of packaging as presentation, identification, protection, convenience and containment. It outlines different types of packaging for solid, semi-solid and liquid products. It also discusses components of packaging including various materials used like glass, plastics, metals and rubbers. Different types of containers and closures are explained along with common packaging types like blister packs.
The document discusses evaluation and stability studies of tablets. It provides details on common tablet tests performed during evaluation including general appearance, hardness, friability, weight variation, disintegration, and dissolution. It also discusses factors affecting drug stability and the various types of stability that must be considered, including chemical, physical, microbiological, therapeutic, and toxicological stability. Guidelines for stability testing from ICH, USP, FDA and other organizations are also summarized regarding testing conditions, frequency, and requirements for re-testing tablets after registration.
This lecture discusses pharmaceutical powders. It begins by defining a pharmaceutical powder as a solid dosage form containing finely divided drugs or chemicals meant for internal or external use. Powders permit drugs to be reduced to a very fine state, enhancing dissolution rate, absorption, and masking unpleasant tastes. The lecture then covers various types of powders including divided powders for internal use (simple, compound, cachet-enclosed), bulk powders (antacids, laxatives), and powders for external use. Methods for reducing particle size like trituration, pulverization, and levigation are also summarized.
This document discusses the labeling of pharmaceutical products. Labeling provides important information for patients, including instructions for appropriate use of medicines. Labels must include the product name, quantity, patient name, dispensing date and pharmacy details. Labels also provide storage instructions, dosage information, potential drug interactions and warnings. Special labeling is required for different types of drug formulations and delivery methods, such as inhalers, capsules, creams and injections. The goal of labeling is to ensure safe use of approved pharmaceutical products and distinguish brands.
This document discusses various aspects of packaging for sterile dosage forms. It begins by defining packaging and describing its purposes such as protecting products and preventing contamination. It then discusses different types of primary, secondary, and tertiary packaging as well as packaging materials like glass, plastic, rubber, and metals. Key characteristics and selection criteria for packaging materials are outlined. The document also covers packaging related topics such as quality assurance, sampling, testing, and validation.
This document provides an overview of tablet formulation and manufacturing. It discusses the definition and advantages of tablets as a popular dosage form. It describes different types of tablets including compressed, enteric coated, and chewable tablets. The document outlines the manufacturing process for compressed tablets including preparation of granules through wet and dry granulation. It also discusses common excipients used in tablet formulations such as diluents, binders, and lubricants. Finally, it provides information on tablet coating techniques and quality evaluation tests for tablets.
Powders are mixtures of finely divided drugs and chemicals that can be used internally or externally. Powders consist of particles that can range in size from 10 mm to 1 μm. The particle size distribution and properties influence how powders can be used. Before using powders to make pharmaceutical products, their chemical and physical characteristics like morphology, purity, solubility, and stability are analyzed. Proper blending and avoiding segregation of powder mixtures is important for ensuring uniform and consistent dosing.
Granules are aggregations of fine powder particles that are roughly spherical in shape. They are produced to improve powder flowability, enhance compressibility, reduce toxicity, and prevent caking. There are three main granulation methods: wet granulation, dry granulation, and granulation by crystallization. Wet granulation is most common and involves mixing powder with a liquid to form a paste, then granulating and drying the paste. Granules are sieved after drying to achieve a uniform size distribution suitable for their intended use as a final or intermediate pharmaceutical product. Quality tests such as dissolution and friability are performed to ensure granule properties are suitable.
This document discusses the manufacture of small volume and large volume parenterals. Small volume parenterals have volumes less than or equal to 100ml and are supplied in single or multiple doses, while large volume parenterals have volumes greater than 100ml and are delivered via intravenous route. The key aspects of formulation include therapeutic agents, vehicles like water for injection, and added substances like antimicrobials, antioxidants and buffers. Terminal sterilization is used to assure sterility of the finished products.
This document provides an overview of the formulation and development of parenteral products. It discusses the key components including containers, closures, processing, formulation, production facilities, and evaluation methods. The production area is divided into five sections - cleanup, preparation, aseptic, quarantine, and finishing/packaging areas. Parenteral formulations contain active drugs, vehicles, and adjuvants. Finished products undergo sterility, clarity, leakage, pyrogen, and assay testing to ensure quality control.
This document provides an overview of semi-solid dosage forms such as ointments, creams, pastes, and gels. It discusses their ideal properties and examples. It also describes the basic introduction, ingredients used in preparation including bases, preservatives, emulsifiers, and gelling agents. Methods of preparation like trituration, fusion, and emulsification are covered. The preparation of oil and aqueous phases and mixing of phases is explained. Finally, the document discusses the storage conditions and references for semi-solid dosage forms.
The document discusses the evaluation and testing of tablets. It describes non-official tests like general appearance, organoleptic properties, size and shape, hardness, and friability. It also describes official tests like weight variation, content uniformity, dissolution, and disintegration. It discusses different types of tablets like compressed and molded tablets. It provides details on evaluating the appearance, hardness, friability and other properties of tablets and describes tests like weight variation, content uniformity, and dissolution used to ensure tablets meet specifications.
This document discusses solid dosage forms known as capsules. It defines capsules as solid dosage forms where the drug is enclosed in a soluble shell, most commonly made of gelatin. There are two main types of capsules: hard gelatin capsules for solids and soft gelatin capsules for liquids. The document outlines the advantages and disadvantages of capsules, as well as methods for filling and evaluating different capsule types.
Ophthalmic products are specialized dosage forms designed for administration to or around the eye. Common types include eye drops, ointments, gels and contact lens solutions. Plastic bottles made of materials like LDPE are widely used for packaging as they are easy to use and reduce spillage compared to older glass bottles. Parenteral products must be exceptionally pure and free from contamination due to direct injection. Common containers include glass vials, syringes and plastic bags or bottles. Rubber stoppers and seals are often used for closures. Proper packaging and container selection is important to prevent issues like permeation, leaching or sorption which could impact drug stability or purity. A variety of tests exist to check package
This document discusses ointments, which are semi-solid topical dosage forms used for therapeutic, protective, or cosmetic purposes. Ointments are greasy preparations containing 80% oil and 20% water that are applied to the skin or mucous membranes. They can contain dissolved, emulsified, or suspended drug ingredients. Ointments are classified based on penetration (epidermic, endodermic, diadermic) or therapeutic use (antibiotic, antifungal, anti-inflammatory). Ideal ointment bases are inert, compatible with skin pH, emollient, and release medication readily. Common bases include oleaginous (petrolatum, hard paraffin, liquid paraffin
Types of closures include threaded screw caps, lug caps, crown caps, roll-on closures, snap caps, and friction fit caps. Quality control of closures considers material compatibility, seal integrity, and sterility. Tests evaluate physical and mechanical properties, extractables and leachables, bioburden, endotoxins, and resistance to sterilization processes. Maintaining closure quality ensures safe and effective packaging of pharmaceuticals and consumer products.
The document describes different types of tablets classified by method of administration and mechanism of action. Tablets can be ingested orally and include standard, enteric coated, chewable and effervescent varieties. Others are used in the oral cavity as buccal, sublingual or lozenges. Implantation and vaginal tablets are administered by other routes. Tablet types aim to protect drugs, modify release timing, or produce solutions for various therapeutic effects.
This document provides an overview of pharmaceutical emulsions. It defines emulsions as dispersions of one liquid in another immiscible liquid, stabilized by an emulsifying agent. The key topics covered include the classification of emulsions as oil-in-water or water-in-oil, theories of emulsification, common emulsifying agents like surfactants and hydrocolloids, and factors affecting the stability of emulsions such as flocculation and creaming. Pharmaceutical applications of emulsions include lotions, creams, and ointments.
This document discusses various types of pharmaceutical excipients used in drug formulations. It defines excipients as pharmacologically inactive substances formulated alongside active pharmaceutical ingredients. Excipients provide bulk, facilitate drug absorption and stability, aid manufacturing, and improve handling. Common excipients include fillers, binders, disintegrants, coatings, preservatives, antioxidants, and solvents. Each excipient type has distinct functions and ideal properties. Proper excipient selection is important to ensure drug efficacy, stability, safety, and to avoid complications.
Liquid dosage forms are effective pharmaceutical products containing a mixture of active pharmaceutical ingredients (API/Drug) and non drug components (excipients). It is a dose of a drug used as a medicine for consumption or administration. Many liquid dosage forms are used in the pharmacy, but the most commonly used are syrup, suspension, and elixirs. The general category of liquid oral doses includes a broad range of dosage forms, broadly classified as monophasic and biphasic. Whereas dosage forms in both types comprise at least one drug, monophasic forms are homogeneous and completely dissolve in liquid, whereas biphasic forms in a vehicle do not dissolve.
This document provides information about tablets, including their definition, advantages, types, and manufacturing process. It begins with definitions of tablets from pharmacopoeias and discusses how they are the most popular dosage form, comprising 70% of pharmaceutical preparations. It describes various types of tablets including compressed, sugar-coated, film-coated, enteric-coated, and effervescent tablets. The document outlines the tablet manufacturing process using tableting machines and discusses characteristics and specifications of compressed tablets.
The document discusses parenterals, which are sterile preparations intended for administration through layers of skin or mucous membranes. It defines parenterals and outlines their advantages like 100% bioavailability and ability to administer to unconscious patients. The document also discusses the various routes of parenteral administration, types of parenterals like powders, solutions, and emulsions. It describes the formulation, layout, and quality control testing of parenterals. Specifically, it provides details on the areas involved in parenteral production, types of small and large volume parenterals, and common quality tests like leaker, clarity, pyrogenic, sterility, and content uniformity testing.
The document discusses creams as a semisolid dosage form containing drug substances dispersed or dissolved in a suitable base. It defines oil-in-water and water-in-oil creams and provides examples of each. The key steps in cream preparation and various tests to characterize creams are described, including determining type of emulsion, viscosity, pH, globule size, stability, and spreadability. Creams offer advantages over other semisolid forms like being less greasy and more easily washed off.
The document discusses parenteral formulations, which are sterile dosage forms administered directly into the body rather than orally. It defines parenterals and describes various types including small and large volume injections, powders, and implants. Key factors in parenteral design are discussed such as drug solubility, vehicle selection, dosage form, ingredients, pH, and color. Common vehicles like water and buffers are outlined. The document also covers routes of administration, isotonicity, production facilities and procedures, and quality control testing for parenteral products.
The document discusses the importance of stability studies for pharmaceutical products. It defines stability as the extent to which a drug substance or product retains its properties within specified limits throughout its shelf life. Stability studies are important for determining shelf life, identifying optimal storage conditions, and ensuring drug efficacy and safety. The key factors that can affect drug stability are temperature, moisture, light, pH, concentration, and drug interactions. The document also discusses the different types of stability, including physical, chemical, and microbiological stability. It outlines the various regulations and guidelines for conducting stability studies.
This presentation summarizes containers and closures used for pharmaceutical products. It defines containers as mechanisms for holding drugs and closures as protecting drugs from contamination. Types of containers discussed include well-closed, single-dose, multi-dosage, light-resistant, airtight, and child-resistant containers. Plastic and glass containers are described along with potential drug interactions. Biological tests for containers including systemic injection, intracutaneous, and eye irritation tests in mice and rabbits are summarized. The conclusion states that dosage form properties determine the suitable container and closure selection.
This document discusses the manufacture of small volume and large volume parenterals. Small volume parenterals have volumes less than or equal to 100ml and are supplied in single or multiple doses, while large volume parenterals have volumes greater than 100ml and are delivered via intravenous route. The key aspects of formulation include therapeutic agents, vehicles like water for injection, and added substances like antimicrobials, antioxidants and buffers. Terminal sterilization is used to assure sterility of the finished products.
This document provides an overview of the formulation and development of parenteral products. It discusses the key components including containers, closures, processing, formulation, production facilities, and evaluation methods. The production area is divided into five sections - cleanup, preparation, aseptic, quarantine, and finishing/packaging areas. Parenteral formulations contain active drugs, vehicles, and adjuvants. Finished products undergo sterility, clarity, leakage, pyrogen, and assay testing to ensure quality control.
This document provides an overview of semi-solid dosage forms such as ointments, creams, pastes, and gels. It discusses their ideal properties and examples. It also describes the basic introduction, ingredients used in preparation including bases, preservatives, emulsifiers, and gelling agents. Methods of preparation like trituration, fusion, and emulsification are covered. The preparation of oil and aqueous phases and mixing of phases is explained. Finally, the document discusses the storage conditions and references for semi-solid dosage forms.
The document discusses the evaluation and testing of tablets. It describes non-official tests like general appearance, organoleptic properties, size and shape, hardness, and friability. It also describes official tests like weight variation, content uniformity, dissolution, and disintegration. It discusses different types of tablets like compressed and molded tablets. It provides details on evaluating the appearance, hardness, friability and other properties of tablets and describes tests like weight variation, content uniformity, and dissolution used to ensure tablets meet specifications.
This document discusses solid dosage forms known as capsules. It defines capsules as solid dosage forms where the drug is enclosed in a soluble shell, most commonly made of gelatin. There are two main types of capsules: hard gelatin capsules for solids and soft gelatin capsules for liquids. The document outlines the advantages and disadvantages of capsules, as well as methods for filling and evaluating different capsule types.
Ophthalmic products are specialized dosage forms designed for administration to or around the eye. Common types include eye drops, ointments, gels and contact lens solutions. Plastic bottles made of materials like LDPE are widely used for packaging as they are easy to use and reduce spillage compared to older glass bottles. Parenteral products must be exceptionally pure and free from contamination due to direct injection. Common containers include glass vials, syringes and plastic bags or bottles. Rubber stoppers and seals are often used for closures. Proper packaging and container selection is important to prevent issues like permeation, leaching or sorption which could impact drug stability or purity. A variety of tests exist to check package
This document discusses ointments, which are semi-solid topical dosage forms used for therapeutic, protective, or cosmetic purposes. Ointments are greasy preparations containing 80% oil and 20% water that are applied to the skin or mucous membranes. They can contain dissolved, emulsified, or suspended drug ingredients. Ointments are classified based on penetration (epidermic, endodermic, diadermic) or therapeutic use (antibiotic, antifungal, anti-inflammatory). Ideal ointment bases are inert, compatible with skin pH, emollient, and release medication readily. Common bases include oleaginous (petrolatum, hard paraffin, liquid paraffin
Types of closures include threaded screw caps, lug caps, crown caps, roll-on closures, snap caps, and friction fit caps. Quality control of closures considers material compatibility, seal integrity, and sterility. Tests evaluate physical and mechanical properties, extractables and leachables, bioburden, endotoxins, and resistance to sterilization processes. Maintaining closure quality ensures safe and effective packaging of pharmaceuticals and consumer products.
The document describes different types of tablets classified by method of administration and mechanism of action. Tablets can be ingested orally and include standard, enteric coated, chewable and effervescent varieties. Others are used in the oral cavity as buccal, sublingual or lozenges. Implantation and vaginal tablets are administered by other routes. Tablet types aim to protect drugs, modify release timing, or produce solutions for various therapeutic effects.
This document provides an overview of pharmaceutical emulsions. It defines emulsions as dispersions of one liquid in another immiscible liquid, stabilized by an emulsifying agent. The key topics covered include the classification of emulsions as oil-in-water or water-in-oil, theories of emulsification, common emulsifying agents like surfactants and hydrocolloids, and factors affecting the stability of emulsions such as flocculation and creaming. Pharmaceutical applications of emulsions include lotions, creams, and ointments.
This document discusses various types of pharmaceutical excipients used in drug formulations. It defines excipients as pharmacologically inactive substances formulated alongside active pharmaceutical ingredients. Excipients provide bulk, facilitate drug absorption and stability, aid manufacturing, and improve handling. Common excipients include fillers, binders, disintegrants, coatings, preservatives, antioxidants, and solvents. Each excipient type has distinct functions and ideal properties. Proper excipient selection is important to ensure drug efficacy, stability, safety, and to avoid complications.
Liquid dosage forms are effective pharmaceutical products containing a mixture of active pharmaceutical ingredients (API/Drug) and non drug components (excipients). It is a dose of a drug used as a medicine for consumption or administration. Many liquid dosage forms are used in the pharmacy, but the most commonly used are syrup, suspension, and elixirs. The general category of liquid oral doses includes a broad range of dosage forms, broadly classified as monophasic and biphasic. Whereas dosage forms in both types comprise at least one drug, monophasic forms are homogeneous and completely dissolve in liquid, whereas biphasic forms in a vehicle do not dissolve.
This document provides information about tablets, including their definition, advantages, types, and manufacturing process. It begins with definitions of tablets from pharmacopoeias and discusses how they are the most popular dosage form, comprising 70% of pharmaceutical preparations. It describes various types of tablets including compressed, sugar-coated, film-coated, enteric-coated, and effervescent tablets. The document outlines the tablet manufacturing process using tableting machines and discusses characteristics and specifications of compressed tablets.
The document discusses parenterals, which are sterile preparations intended for administration through layers of skin or mucous membranes. It defines parenterals and outlines their advantages like 100% bioavailability and ability to administer to unconscious patients. The document also discusses the various routes of parenteral administration, types of parenterals like powders, solutions, and emulsions. It describes the formulation, layout, and quality control testing of parenterals. Specifically, it provides details on the areas involved in parenteral production, types of small and large volume parenterals, and common quality tests like leaker, clarity, pyrogenic, sterility, and content uniformity testing.
The document discusses creams as a semisolid dosage form containing drug substances dispersed or dissolved in a suitable base. It defines oil-in-water and water-in-oil creams and provides examples of each. The key steps in cream preparation and various tests to characterize creams are described, including determining type of emulsion, viscosity, pH, globule size, stability, and spreadability. Creams offer advantages over other semisolid forms like being less greasy and more easily washed off.
The document discusses parenteral formulations, which are sterile dosage forms administered directly into the body rather than orally. It defines parenterals and describes various types including small and large volume injections, powders, and implants. Key factors in parenteral design are discussed such as drug solubility, vehicle selection, dosage form, ingredients, pH, and color. Common vehicles like water and buffers are outlined. The document also covers routes of administration, isotonicity, production facilities and procedures, and quality control testing for parenteral products.
The document discusses the importance of stability studies for pharmaceutical products. It defines stability as the extent to which a drug substance or product retains its properties within specified limits throughout its shelf life. Stability studies are important for determining shelf life, identifying optimal storage conditions, and ensuring drug efficacy and safety. The key factors that can affect drug stability are temperature, moisture, light, pH, concentration, and drug interactions. The document also discusses the different types of stability, including physical, chemical, and microbiological stability. It outlines the various regulations and guidelines for conducting stability studies.
This presentation summarizes containers and closures used for pharmaceutical products. It defines containers as mechanisms for holding drugs and closures as protecting drugs from contamination. Types of containers discussed include well-closed, single-dose, multi-dosage, light-resistant, airtight, and child-resistant containers. Plastic and glass containers are described along with potential drug interactions. Biological tests for containers including systemic injection, intracutaneous, and eye irritation tests in mice and rabbits are summarized. The conclusion states that dosage form properties determine the suitable container and closure selection.
This document discusses various ophthalmic products including eye drops, eye lotions, eye suspensions, eye ointments, and contact lens solutions. It describes the ideal characteristics of ophthalmic products such as being sterile, isotonic, and having the proper pH and viscosity. It also discusses the types of microorganisms that can cause eye infections and how sterility is achieved. The document provides details on the formulation, preparation, and labeling of different ophthalmic products.
This document discusses various techniques for extracting phytochemicals from medicinal plants, including maceration, infusion, percolation, digestion, decoction, hot continuous extraction, aqueous-alcoholic extraction, counter-current extraction, microwave-assisted extraction, and ultra-sound extraction. It provides detailed step-by-step explanations of each extraction technique. The goal of extraction is to separate medicinal active compounds from plant materials using solvents and standard procedures.
The Willowbank Pharmacy newsletter provides tips for safely storing medications. Key points include:
- Store medications below 25°C in a cool, dry, dark place away from heat, light and moisture to prevent breakdown.
- Leave medications in original containers and check expiry dates regularly.
- Some medications like eye drops need to be discarded after a set time once opened.
- Keep medications locked away and out of reach of children.
- Only store medications in the fridge if specifically instructed to do so on the label.
The Willowbank Pharmacy newsletter provides tips for safely storing medications. Key points include:
- Store medications below 25°C in a cool, dry, dark place away from heat, light and moisture to prevent breakdown.
- Leave medications in original containers and check expiry dates regularly.
- Some medications like eye drops need to be discarded after a set time once opened.
- Keep medications locked away and out of reach of children.
- Only store medications in the fridge if the label specifies; fluctuations in temperature can damage some medications.
- When traveling, keep medications cool and dry, such as in an insulated bag, and take an extra supply in case of delays.
This document discusses drug stability and the factors that affect it. It defines drug stability as the ability of a pharmaceutical dosage form to maintain its physical, chemical, therapeutic, and microbial properties during storage and use. Expiry dates indicate the last date a drug can be used as the drug concentration decreases over time. Several factors can influence drug stability, including temperature, pH, moisture, light, dosage form, concentration, drug incompatibility, oxygen, and packaging. Proper formulation and packaging are important to ensure drug stability and prevent degradation.
introduction to dosage form with reference to dispensing by urooj umeruroojumer1
The document provides an introduction to dosage forms and their dispensing. It discusses the key requirements for proper dosage form design and formulation. The main types of dosage forms are described as solid, liquid, semi-solid and gaseous. Specific examples are outlined for each category. The process of dispensing for different dosage forms is also explained, covering topics like packaging, storage conditions and patient instructions.
Proper storage of medications is important to ensure potency and prevent misuse. Medications should generally be stored below 25°C in a dark, dry place such as a closet or cabinet away from heat, light, and moisture. Original containers should be kept with expiration dates tracked. Refrigerated medications require similar care and should not be frozen. When traveling, medications require insulation and cooling on hot days to maintain stability. Pharmacists can provide advice on storage or eligibility for medication management programs.
The document discusses various types of pharmaceutical preparations and tablets. It defines pharmaceutical preparations as medicinal products consisting of active substances that may be combined with excipients and formulated into a suitable dosage form. There are two categories of unlicensed preparations: extemporaneous preparations made for a specific patient, and stock preparations made in advance. Tablets are a common dosage form and come in various types including uncoated, coated, gastro-resistant, and modified-release tablets. The document discusses the formulation, advantages, and characteristics of tablets. It also describes the desired properties of active pharmaceutical ingredients and various excipients used in tablet formulations like diluents, binders, lubricants, and disintegrants.
This document discusses orally disintegrating tablets (ODTs). It defines ODTs as solid dosage forms that disintegrate rapidly in the mouth within seconds. The document outlines the significance of ODTs for patients who have difficulty swallowing tablets or need a more convenient dosage form. It also discusses the formulation methodologies, superdisintegrants used in ODTs, and preformulation studies required for developing ODTs.
1) Parenteral products must be sterile, non-pyrogenic, and free of particulate matter as they are administered directly into the body.
2) Key factors in formulating parenterals include the vehicle, drug volume, adjusting isotonicity and pH, inclusion of stabilizers and preservatives, and ensuring the appropriate concentration and osmotic pressure.
3) Sterilization of parenterals can be achieved through various moist heat methods like autoclaving, dry heat like oven sterilization, or chemical methods using gases like ethylene oxide.
This document discusses pharmaceutical preparations and tablets. It defines pharmaceutical preparations as medicinal products consisting of active substances that may be combined with excipients and formulated into a suitable dosage form. The document outlines different types of pharmaceutical preparations including licensed and unlicensed preparations. It also discusses production requirements and testing. The document focuses on tablets, defining them and outlining different tablet categories. It discusses characteristics, advantages, and disadvantages of tablets. The document covers desired properties of active pharmaceutical ingredients and excipients used in tablet formulations. It provides details on commonly used excipients like diluents, binders, lubricants, and their functions in tablet formulations.
This document discusses poisons and falls in a hospital setting. It defines a poison as a substance that damages living tissues and has harmful or fatal effects. Poisoning in hospitals can occur through prolonged medication use, overdoses, inhalation of cleaning chemicals, and contaminated food. Dangers of poisoning include seizures, gastrointestinal issues, breathing difficulties, coma, organ damage, and rashes. Prevention methods include securely storing poisons, proper labeling of chemicals, and disposal of old medications. Falls are defined as losing balance and collapsing or moving from high to low levels quickly without control. Falls can be caused by slippery floors, medication side effects, impaired vision, and improper waste disposal. Dangers of falls include injuries,
EXCIPIENT USED IN PARENTRALS AND AEROSOLS.pptxDhruv Bhavsar
This document discusses various excipients used in parenteral (injectable) and aerosol drug formulations. It describes the functions of different types of excipients such as bulking agents, lyoprotectants, buffers, tonicity adjusting agents, antioxidants, preservatives, solubilizing agents, and others. It provides examples of commonly used excipients for each category and discusses some of their properties and how they contribute to drug formulations. The document is intended to educate readers about the excipients that are added to injectable and aerosol drugs to aid manufacturing, improve stability and safety, and modify drug delivery properties.
Parenterals are sterile solutions, emulsions or suspensions of drugs intended for administration through a non-oral route. This document discusses various aspects of parenterals including advantages and disadvantages, routes of administration, types, components, quality control, and sterilization. Parenterals can be small volume solutions, suspensions or emulsions packaged in vials or bags of 100ml or less, or large volume solutions contained in glass bottles or bags over 100ml including hyperalimentation, cardioplegic, and dialysis solutions. Quality is ensured through testing of sterility, clarity, leakage, pyrogens and other parameters.
Similar to labeling,storage and stability of pharmaceutical dosage forms and beyond use date.ppt (20)
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
Philippine Edukasyong Pantahanan at Pangkabuhayan (EPP) CurriculumMJDuyan
(𝐓𝐋𝐄 𝟏𝟎𝟎) (𝐋𝐞𝐬𝐬𝐨𝐧 𝟏)-𝐏𝐫𝐞𝐥𝐢𝐦𝐬
𝐃𝐢𝐬𝐜𝐮𝐬𝐬 𝐭𝐡𝐞 𝐄𝐏𝐏 𝐂𝐮𝐫𝐫𝐢𝐜𝐮𝐥𝐮𝐦 𝐢𝐧 𝐭𝐡𝐞 𝐏𝐡𝐢𝐥𝐢𝐩𝐩𝐢𝐧𝐞𝐬:
- Understand the goals and objectives of the Edukasyong Pantahanan at Pangkabuhayan (EPP) curriculum, recognizing its importance in fostering practical life skills and values among students. Students will also be able to identify the key components and subjects covered, such as agriculture, home economics, industrial arts, and information and communication technology.
𝐄𝐱𝐩𝐥𝐚𝐢𝐧 𝐭𝐡𝐞 𝐍𝐚𝐭𝐮𝐫𝐞 𝐚𝐧𝐝 𝐒𝐜𝐨𝐩𝐞 𝐨𝐟 𝐚𝐧 𝐄𝐧𝐭𝐫𝐞𝐩𝐫𝐞𝐧𝐞𝐮𝐫:
-Define entrepreneurship, distinguishing it from general business activities by emphasizing its focus on innovation, risk-taking, and value creation. Students will describe the characteristics and traits of successful entrepreneurs, including their roles and responsibilities, and discuss the broader economic and social impacts of entrepreneurial activities on both local and global scales.
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxEduSkills OECD
Iván Bornacelly, Policy Analyst at the OECD Centre for Skills, OECD, presents at the webinar 'Tackling job market gaps with a skills-first approach' on 12 June 2024
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
This document provides an overview of wound healing, its functions, stages, mechanisms, factors affecting it, and complications.
A wound is a break in the integrity of the skin or tissues, which may be associated with disruption of the structure and function.
Healing is the body’s response to injury in an attempt to restore normal structure and functions.
Healing can occur in two ways: Regeneration and Repair
There are 4 phases of wound healing: hemostasis, inflammation, proliferation, and remodeling. This document also describes the mechanism of wound healing. Factors that affect healing include infection, uncontrolled diabetes, poor nutrition, age, anemia, the presence of foreign bodies, etc.
Complications of wound healing like infection, hyperpigmentation of scar, contractures, and keloid formation.
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
Temple of Asclepius in Thrace. Excavation resultsKrassimira Luka
The temple and the sanctuary around were dedicated to Asklepios Zmidrenus. This name has been known since 1875 when an inscription dedicated to him was discovered in Rome. The inscription is dated in 227 AD and was left by soldiers originating from the city of Philippopolis (modern Plovdiv).
labeling,storage and stability of pharmaceutical dosage forms and beyond use date.ppt
1. Introduction to pharmacy and
pharmaceutic
Labeling, storage and stability of pharmaceutical
dosage form and beyond use date
[DEPARTMENT OF PHARMACY]
By tujar kaso (b pharm)
2. objectives
1. LABELING OF PHARMACEUTICAL DOSAGE FORMS
» define the term lebel
» discuss properties and importance of labeling
» discuss informations on the labels
» dicuss Special instructions for particular type of product
2. STORAGE OF DOSAGE FORMS
» Define meaning of storage
» Discuss need for storage of dosage form
» Discuss storage conditions for storing different dosage
forms
» discuss different containers used for storage
3. 3. STABILITY OF PHARMACEUTICAL DOSAGE FORMS
» Define drug stability
» Discuss factors that influence drug stability in different
dosage forms
4. DISCUSS BEYOND-USE DATE
5. • Label
label means display of printed information which
is securely affixed to the container and primally
packaging containing the medicine.
label should provide the patient with all
necessary information:
» General labeling requirement
» Cautionary and advisory label
» Special instruction for different type of product.
6. Properties of lebel:
• Information given on label should be:
»Accurate
»Legible
»Intelligible
»Adequate and relevant
7. Importance of label:
• to provide consumers with information on
the label
• to ensure the appropriate and safe use of
approved drug
• To distinguish the product from that of
competitors(establish a brand)
• a legal requirement
8. Information on the label:
• includes the name and address of supplier
and date of supply
• give precise details as the content of the
container:
» Name of the medicine
» Quantity of the container
» the strength of the medicine: represents the amount of
active ingredient in each dosage unit(/tab,/cap,/ml)
» Units: as a whole number unit, example:100mg rather
than 0.1g
» Batch identification and
» dilute product: indicate the degree of dilution.
9. • state the storage conditions and shelf life of
the product
» Temperature
» Humidity
» Light
» Shelf life
• give the patient clear and complete
instruction on ha to take or use the product
– Direction
» Amount of rug to be taken
» Frequency and timing of administrating
» Route of administration
10. Cautionary and advisory labels:
• for external use only:
»Ointment
»Creams
»Dusting powder
• keep out of reach of children
• for animal treatment only
11. Recommended cautionary and advisory
labels:
• drowsiness warnings
• potential interaction with other medicine
• potential interaction with food or drink
• Special method of administration:
» with plenty of water
» Dissolve under the tangue
» swallow whole, not chewed
» dissolve or mix with water before taking
12. Special instructions for particular type of
product:
• pressurized inhalation:
» Shake before using
» Pressurized ontainer
» keep away from heat source
• capsules:
» Swallow whole with drought of water
13. • creams:
» For external use only
» Store in cool place
» Donot freeze
• dusting powders:
» For external use only
» Not to be applied to open wounds or weeping surface
• emulsion:
» shake the bottle
14. • enemas:
» for rectal use only
» Shake before use
• eye drops:
» Avoid contamination in use
» discard 28 days after first opening.
• gargle and mouthwash:
» not to be swallowed in large amount
• gel:
» For external use only
15. • ointment,pastes,paints:
» for external use only
• tablets:
» Dissolve or disperse in water before use
• for chewable tablet:
» Chew before swallowing
• for sustained release/enteric coated tablet:
» do not chew or crush
17. DEFINITIONS : -
DOSAGE FORM:
• Completed form of the pharmaceutical preparation
in which prescribed doses of medication are
included. Examples: Tablets, Liniments, Ointments,
Powders ,Lotions etc.
STORAGE:
• It simply means keeping things at a place ,till it is
used ,so as to preserve the same properties.
18. NEED FOR STORAGE OF DOSAGE
FORMS
• If the drug is not properly stored and on exposure to
air, heat, light and microbes results in degradation
,loss of efficacy and even cause toxicity.
• Light can bring about photolytic decomposition due
to exposure to certain wave length of light.
• Air present inside the container may catalyse
oxidative degradation or other chemical changes.
• Moisture effects the stability of moisture sensitive
preparation.
19. Sterile products are required to maintain sterility
implying exclusion of microbes.
Certain drugs on exposure to air undergoes auto-
oxidation and emulsified lipids are sensitive to
attack. So proper storage of drugs is required which
are sensitive to air, light, moisture.
The stability of drug depends on temperature and
pH.
ex:- Ampicillin is stored at low temperatures (2 – 8 c).
Ampicillin in solution is not stable at pH > 7.
20. STORAGE CONDITIONS FOR
STORING DIFFERENT DOSAGE
FORMS
Dosage
form
Drug Storage condition Use
Tablets Paracetamol Store it at room
temperature
Keep away from excess
heat and moisture.
Analgesic,
Anti-pyretic,
Anti- inflammatory
Capsule B-complex Keep in brown
colour/amber colour glass
bottles to protect from light.
Store it room temperature.
vitamin
supplement
syrup codeine Keep it in brown colour
glass bottle to protect from
light. Keep in cool place.
Anti-tussive,
Anti-diarrhoel,
Analgesic.
21. Lotion Calamine Store in well closed
container
protective
Emulsion Liquid paraffin
Porcelis pestis
emulsion.
Store in glass container
and keep in cool place
Store at 2 – 8 c . Should
be 15 – 25 c before use.
laxative.
To decrease
swine fever in
pigs.
Suspension Milk of
msagnesia
Store in a cool in and dark
place and keep in air tight
plastic containers.
Antacid.
Ointment clotrimazole Store in acool and dark
place.keep in plastic
tubes.
Anti-fungal.
22. Cream Extract of
jivanti,manjisth
a (ayurvedic)
Store in cool and dark
place. Keep in plastic
tubes.
Healing and
soothing of
wounds.
Parenterals Ampicillin Vials should be stored
at 2 – 8 c for 3 weeks.
For long storage they
should be stored at
-20 c for 4 – 6 months.
Anti-biotic
Opthalamic Tetrazoline Hcl Store in low
temperature and keep
them in amber colour
glass bottles.
used when
irritation and
redness caused
by cold
Powders clotrimazole Store in cool and dark
place in a plastic
container.
Anti-fungal
Gel aloe Store in cool and dark
place away from direct
sunlight
23. DIFFERENT CONTAINERS USED FOR
STORAGE
1. WELL CLOSED:-It protects the container from
contamination with extraneous solids under
normal conditions of storage, handling, transport &
prevent unintentional release of the contents.
2. AIR TIGHT :-It gives protection against extraneous
solids, liquids, vapours under normal conditions of
storage, handling, transport. It prevents changes
due to efflorescence, deliquescence, &
evaporation.
24. 3.SECURELY CLOSED:- This is a air tight container
with a means of preventing unintentional
displacement of the closure.
4.HERMETICALLY CLOSED:-It is impervious to air
and other gases under normal conditions of
storage, handling & transport. Ex:- Glass
ampoule sealed by fusion.
25. Liquid oral preparations
a) Intended to be swallowed (elixirs ,emulsions)
-Glass bottles
b) Not intended to be swallowed ( mouth washes , gargles)
- Ribbed oval glass bottles
Semisolid preparations - creams ,jellies ,ointments
-Collapsible metal or plastic tubes
-Glass or plastic pots.
CONTAINERS FOR DIFFERENT
DOSAGE FORMS
26. • Solid unit dose preparations :-
a) Intended to be swallowed or sucked
(Cachets, soft & hard capsules, pills )
b) Intended for use in body cavities
-Glass ,plastics ,aluminium
-plastic ,metal containers
c) powders
1)For oral administration
Bulk powders -Glass & plastic
2) For external use –
Dusting - used in body cavities .
insuffalations -Air tight glass/plastic
container
29. Drug stability
• Drug stability means the ability of pharmaceutical
dosage form to maintain the
physical,chemical,therapeutic and microbial
propertis during the time of storage and usage by
patient.
30. Factors influencing drug stability
• in liquid dosage form:
» ph
»Temperature
»Solvent effect
»Oxygen
»Light
»surfactant
31. • in solid dosage form:
»Moisture
»Excipient
»Temperature
»Light and oxygen
32. In liquid dosage form:
• PH:- ph is the most important parameter
which affect the hydrolysis rate of drugs in
liquid formulation.
• the influence of ph on the degradation rate is:
»Specific acid base catalysis
» different ph rate profile obtained using
different buffer
33. • TEMPERATURE:- increase in temperature
usually causes a very pronounced increase in
hydrolysis rate of drug in solution.
• OXYGEN:-molecular oxygen is involved in
many oxidation particularly drug is likely to be
affected by oxidative breakdown.
• LIGHT:-exposure to ultra violate light is the
most usual cause of photodegradation.
34. • photolabile drugs are usually stored in
container which exclude ultraviolet light.
• SURFACTANT:- the presence of surfactant in
micellar form has a modifying effect on the
hydrolysis of drug.
35. IN SOLID DOSAGE FORM:
• MOISTURE:- water soluble drugs present in a solid
dosage form dissolves in any moisture which has
adsorbed on the solid surface.
• EXCEPIENT:- excipient with particularly high water
contents, affects stability by increasing the water
content of the formulation.
• TEMPERATURE:- the effect of temperature change
on the stability of solid dosage forms can be
complicated for many possible reasons:-
36. • the drug or one of the excipient may melt or
change its polymorphic form as temperature is
increased
• the drug or one of the excipient may contain
loosely bound water which is lost at high
temperature.
37. BEYOND USE DATE
• Beyond use date is the date after which a
product shall not be used. The dispenser shall
place on the label of the prescription
container a suitable beyond use date to limit
the patients use of the article based o any
information supplied by the manufacturer.
• the beyond use date shall not be later than
the expiration date on the manufacturer
container.
38. • For all dosage forms in determining beyond
use date the dispenser shall take in to account
in addition to any other relevant factors:
»Nature of the drug
» container in which it was packed
» storage condition
» length of the therapy